BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11829604)

  • 1. Quantitative measurements of recombinant HIV surface glycoprotein 120 binding to several glycosphingolipids expressed in planar supported lipid bilayers.
    Conboy JC; McReynolds KD; Gervay-Hague J; Saavedra SS
    J Am Chem Soc; 2002 Feb; 124(6):968-77. PubMed ID: 11829604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-natural glycosphingolipids and structurally simpler analogues bind HIV-1 recombinant Gp120.
    McReynolds KD; Bhat A; Conboy JC; Saavedra SS; Gervay-Hague J
    Bioorg Med Chem; 2002 Mar; 10(3):625-37. PubMed ID: 11814851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric synthesis of water-soluble analogues of galactosylceramide, an HIV-1 receptor: new tools to study virus-glycolipid interactions.
    Villard R; Hammache D; Delapierre G; Fotiadu F; Buono G; Fantini J
    Chembiochem; 2002 Jun; 3(6):517-25. PubMed ID: 12325007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3.
    Hammache D; Piéroni G; Yahi N; Delézay O; Koch N; Lafont H; Tamalet C; Fantini J
    J Biol Chem; 1998 Apr; 273(14):7967-71. PubMed ID: 9525894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A convenient oxidation of natural glycosphingolipids to their "ceramide acids" for neoglycoconjugation. Bovine serum albumin-glycosylceramide acid conjugates as investigative probes for HIV gp120 coat protein-glycosphingolipid interactions.
    Mylvaganam M; Lingwood CA
    J Biol Chem; 1999 Jul; 274(29):20725-32. PubMed ID: 10400707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
    Delézay O; Hammache D; Fantini J; Yahi N
    Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide.
    Long D; Berson JF; Cook DG; Doms RW
    J Virol; 1994 Sep; 68(9):5890-8. PubMed ID: 8057468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of biotinylated glycoconjugates and their use in a novel ELISA for direct comparison of HIV-1 Gp120 recognition of GalCer and related carbohydrate analogues.
    McReynolds KD; Hadd MJ; Gervay-Hague J
    Bioconjug Chem; 1999; 10(6):1021-31. PubMed ID: 10563771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous interbilayer transfer of hexosylceramides between phospholipid bilayers.
    Jones JD; Almeida PF; Thompson TE
    Biochemistry; 1990 Apr; 29(16):3892-7. PubMed ID: 2354161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide.
    Weber KT; Hammache D; Fantini J; Ganem B
    Bioorg Med Chem Lett; 2000 May; 10(10):1011-4. PubMed ID: 10843204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosphingolipid acyl chain order profiles: substituent effects.
    Morrow MR; Singh D; Grant CW
    Biochim Biophys Acta; 1995 May; 1235(2):239-48. PubMed ID: 7756331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4.
    Harrop HA; Rider CC
    Glycobiology; 1998 Feb; 8(2):131-7. PubMed ID: 9451022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosphingolipid fatty acid arrangement in phospholipid bilayers: cholesterol effects.
    Morrow MR; Singh D; Lu D; Grant CW
    Biophys J; 1995 Jan; 68(1):179-86. PubMed ID: 7711240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization and sorting of a fluorescent analogue of glucosylceramide to the Golgi apparatus of human skin fibroblasts: utilization of endocytic and nonendocytic transport mechanisms.
    Martin OC; Pagano RE
    J Cell Biol; 1994 May; 125(4):769-81. PubMed ID: 8188745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop.
    Cook DG; Fantini J; Spitalnik SL; Gonzalez-Scarano F
    Virology; 1994 Jun; 201(2):206-14. PubMed ID: 8184533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275.
    Bhat S; Mettus RV; Reddy EP; Ugen KE; Srikanthan V; Williams WV; Weiner DB
    AIDS Res Hum Retroviruses; 1993 Feb; 9(2):175-81. PubMed ID: 8457384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins.
    Mahfoud R; Manis A; Binnington B; Ackerley C; Lingwood CA
    J Biol Chem; 2010 Nov; 285(46):36049-59. PubMed ID: 20716521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids.
    Planes R; Bahraoui E
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis.
    Burger KN; van der Bijl P; van Meer G
    J Cell Biol; 1996 Apr; 133(1):15-28. PubMed ID: 8601603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120.
    Augustin LA; Fantini J; Mootoo DR
    Bioorg Med Chem; 2006 Feb; 14(4):1182-8. PubMed ID: 16216516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.